| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 09/12/2002 | US20020127619 Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins |
| 09/12/2002 | US20020127282 Utilized to preserve pharmaceutical, cosmetic and chemical specialty products against bacteria, fungi and algae |
| 09/12/2002 | US20020127281 Stabilized hyrogen peroxide solutions |
| 09/12/2002 | US20020127183 Solvent for liquid ingredients to be used in effervescent products |
| 09/12/2002 | DE10139399A1 Wound healing composition, especially useful for post-operative wounds, comprising acidic aqueous solution containing zinc and iron ions |
| 09/12/2002 | CA2442396A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439802A1 Immune response potentiation |
| 09/12/2002 | CA2439413A1 Virucidal compositions |
| 09/11/2002 | EP1238946A1 Production method of ultrafine gold particle-dissolved water and device therefor |
| 09/11/2002 | EP1238675A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/11/2002 | EP1237576A1 Antiviral agent for use in treatment of cancer |
| 09/11/2002 | EP1237553A2 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 09/11/2002 | EP1166291A4 Heating of magnetic material by hysteresis effects |
| 09/11/2002 | EP0904089B1 Sterilization of female mammals |
| 09/11/2002 | EP0797445B1 Use of bioassimilable aqueous boron compounds for the control of subviral pathogenic agents |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1368378A Efficient medicine for treating foot tinea and berberi |
| 09/11/2002 | CN1368376A Medicine for treating mastoplasia |
| 09/11/2002 | CN1368173A Tonglinxiaozheng Particles for treating carcinoma of urinary bladder and its preparing process |
| 09/11/2002 | CN1090500C Medicine for treating gynaecdogic pelvic tumour and preparation method thereof |
| 09/11/2002 | CN1090495C Jieyinjing washing liquid for cleaning pudendum and preparation method thereof |
| 09/11/2002 | CN1090494C Medicine for treating aplastic anemia acute granulocytic leukemia and chronic granulocytic leukemia |
| 09/11/2002 | CN1090492C Ointment for treating skin tinea |
| 09/11/2002 | CN1090486C Chinese patent medicine for treating cancer metastasis |
| 09/11/2002 | CN1090483C Potassium and magnesium controlled-release tablet and producing method thereof |
| 09/11/2002 | CN1090482C Massage oil for human skin |
| 09/10/2002 | US6448238 Inhibitors of β-lactamases and uses therefor |
| 09/10/2002 | US6447810 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
| 09/10/2002 | US6447809 Composition for promoting healthy bone structure |
| 09/10/2002 | US6447763 Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells |
| 09/10/2002 | US6447757 Teeth whitening composition with increased bleaching efficiency and storage stability |
| 09/10/2002 | CA2053933C Nutritional composition comprising hydrolysed soluble fiber |
| 09/06/2002 | WO2002067953A2 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 09/06/2002 | WO2002067879A2 Material composition and oral galenic form against hair loss and brittle nails |
| 09/06/2002 | WO2002067853A2 A combination and method of treatment of hiv and viral diseases, vascular disease and cancer utilizing a cox-2 inhibitor and cystine |
| 09/06/2002 | WO2002067831A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | WO2002067681A1 Restore cancer-suppressing functions to neoplastic cells through dna hypomethylation |
| 09/06/2002 | WO2002053094A3 Method for detoxifying a carbohydrate containing solution |
| 09/06/2002 | WO2002043659A3 Composition containing statins and calcium for improved cardiovascular health |
| 09/06/2002 | WO2002040062A3 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 09/06/2002 | CA2438630A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | CA2438063A1 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 09/05/2002 | US20020123469 Antiproliferative colchicine compositions and uses thereof |
| 09/05/2002 | US20020123051 Tumor therapy; obtain tissue, incubate with antitumor agents, fix tissue, isolate nucleotide sequences, amplify and monitor gene expreesion in sample |
| 09/05/2002 | US20020122834 Method and composition for improving fertility health in female and male animals and humans |
| 09/05/2002 | US20020122832 Organic matrix containing homogeneously dispersed particles of a metallic silver having a particle size in the range of 1 to 50 nm (silver nanoparticles) |
| 09/05/2002 | US20020122822 Having a friability of less than about 2% from an active ingredient, an excipient in the form of a hydrate, and a water- swellable excipient; and applying energy to decrease the hardness of the tablet by at least 20%. |
| 09/05/2002 | US20020122814 Nitric oxide associated with and releasable from a polyurea network formed from reaction (a) a polyisocyanate; (b) an amine donor; (c) an isocyanatosilane adduct having a terminal isocyanate group and an alkoxysilane group |
| 09/04/2002 | EP1236475A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | EP1235582A1 Methods and kits for use in preventing restenosis |
| 09/04/2002 | EP1235558A2 Compressed tablet composition comprising a nsaid |
| 09/04/2002 | EP1235487A1 Nutritional composition |
| 09/04/2002 | EP1049478B1 Composition containing propargylamine for enhancing cancer therapy |
| 09/04/2002 | EP0971690B1 Antiinfective free intramammary veterinary composition |
| 09/04/2002 | EP0920309B1 Conjugated linoleic acid to maintain or enhance bone mineral content |
| 09/04/2002 | EP0792143B1 Methods for making liposomes containing hydrophobic drugs |
| 09/04/2002 | CN1367701A Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2002 | CN1367690A Combination therapy using pentafluorobenzenesulfonamide |
| 09/04/2002 | CN1367011A Medicine for external application for curing dermal viral infection and its preparation method |
| 09/04/2002 | CN1367004A Medicine for curing cancers |
| 09/04/2002 | CN1366997A Liquid medicine for curing beriberi |
| 09/04/2002 | CN1366991A Application of plant extract for preparing medicine to cure bone absorption increment diseases |
| 09/04/2002 | CN1366884A Suangyang zits removing agent |
| 09/03/2002 | US6444700 Nutrient mixture of vitamin c and e, beta-carotene, selenium and glyceride |
| 09/03/2002 | US6444699 Method for treatment of aging or damage skin |
| 09/03/2002 | US6444418 Plasma-like solution |
| 09/03/2002 | US6444232 Aqueous suspension |
| 09/03/2002 | US6444231 Catalysis of the transfer of the gamma phosphate of adenosine triphosphate to tyrosine residues of proteins or polypeptides; combined with insulin as an antidiabetic agents |
| 09/03/2002 | US6444219 An antiseptic sealed package of solid dry admixed polyvinylpyrrolidone-cinnamic alcohol emulsion, the external surface of emulsion carries a coating of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon |
| 09/03/2002 | US6444218 Soft chewable multivitamin tablet comprising separated active ingredients |
| 09/03/2002 | CA2072949C Stick composition with sodium chloride and stearyl alcohol |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066065A1 Calcium supplementation to reduce prostate cancer risk |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066040A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 08/29/2002 | WO2002065981A2 Chemotherapeutic composition using calcium phosphate paste |
| 08/29/2002 | WO2002007700A3 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates |
| 08/29/2002 | WO2002000227A3 Use of lanthanum compounds for the treatment of bone diseases |
| 08/29/2002 | WO2001017364A9 Food product and process for manufacturing same |
| 08/29/2002 | US20020119955 Modified prodrug forms of AP/AMP |
| 08/29/2002 | US20020119933 Administering ribose; cardiovascular disorders |
| 08/29/2002 | US20020119566 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 08/29/2002 | US20020119430 Hypnotist referral network |
| 08/29/2002 | US20020119307 Substrate with a photocatalytic coating |
| 08/29/2002 | US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms |
| 08/29/2002 | US20020119205 Therapy; as disinfectant for skin or other body surfaces or body cavities; incorporated into bandages, films, sutures; non-staining |
| 08/29/2002 | US20020119202 For therapy of cancer and other angiogenic-dependent diseases |
| 08/29/2002 | US20020119174 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates |
| 08/29/2002 | US20020119095 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/28/2002 | EP1234585A2 Methods and compositions for the prevention or treatment of cancer |
| 08/28/2002 | EP1233930A1 A particle comprising a host lattice and a guest, its preparation and use in ultraviolet light screening compositions |
| 08/28/2002 | EP1233811A2 Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use |
| 08/28/2002 | EP1233772A1 Boron compounds and complexes as anti-inflammatory agents |
| 08/28/2002 | EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 08/28/2002 | EP0806956B1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment |